Professor Didier Merlin's investigations into KPV's gastrointestinal activity have revealed its potential to enter colonic cells via PepT1, predominantly expressed during inflammatory states, elucidating its enhanced activity in inflamed settings
The SURMOUNT-1 Phase 3 trial published in the New England Journal of Medicine demonstrated 20.9% mean body weight reduction at 72 weeks on tirzepatide 15mg weekly versus 3.1% with placebo
319 Thymosin 4 alleviates MAFLD by inhibiting ferroptosis through GPX4 upregulation
Singla N, Inavolu P, Kumar B, Macherla R, Reddy D (2024) SARC-F Score: a quick bedside tool to screen sarcopenia in patients with cirrhosis
,
This energy is used by the body for various processes, such as muscle contraction, the synthesis of new molecules, and the maintenance of cellular structures